產(chǎn)品搜索
產(chǎn)品分類(lèi)
相關(guān)文章
- 【產(chǎn)品推介】腫瘤融合基因檢測(cè)及靶向治療
- 科學(xué)家如何深度破解癌癥基因組的奧秘?
- 探討腫瘤細(xì)胞的“冷與熱”之分
- FGFR3-TACC3融合藥物細(xì)胞篩選模型
- 研究發(fā)現(xiàn)氣候可能決定人的鼻子形狀
- 【靶點(diǎn)模型+診斷質(zhì)控】BTK C481S的藥物開(kāi)發(fā)和診斷
- 分子診斷標(biāo)準(zhǔn)品,選擇科佰生物
- 【連載-企業(yè)參考品】肺癌PCR和NGS參考品的選擇
- IDH基因診斷標(biāo)準(zhǔn)品
- ATCC細(xì)胞株的特殊性質(zhì)或標(biāo)志必須在整個(gè)培養(yǎng)期間始終存在
聯(lián)系我們
電話(huà):4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73287BCR-ABL1 Y253H/BaF3激酶細(xì)胞株
- 詳細(xì)內(nèi)容
CBP73287 | |
I. Introduction | |
Cell Line Name: | BCR-ABL1 [Y253H]/BaF3 |
Host Cell: | Ba/F3 |
Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Anti-proliferation assay and PD assay |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS |
Mycoplasma Status: | Negative |
II.Background | |
Presence of a BCR-ABL1 fusion gene is necessary for the pathogenesis of CML. In up to 95% of cases, a t(9;22) (q34;q11) translocation results in the BCR-ABL1 fusion gene (Faderl et al. 1999). This translocation results in the Philadephia chromosome. In rare CML cases lacking the traditional t(9;22) translocation, other translocations result in the creation of the BCR-ABL1 fusion gene, which sometimes involve multiple chromosomes. | |
III. Representative Data | |
1. WB of BCR-ABL1 [Y253H]/BaF3 | |
2.Sanger of BCR-ABL1 [Y253H]/BaF3 Figure 2. BCR-ABL1 Y253H Figure 3. BCR-ABL1 [Y253H]/BaF3 Fusion | |
3. Anti-proliferation assay Figure 4. CTG Proliferation Assay of BaF3 BCR-ABL1 Y253H Cells (C1). | |